4.6 Article

Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment

Related references

Note: Only part of the references are listed.
Review Allergy

A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis

Maria-Grazia Lazzaroni et al.

Summary: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by vasculopathy, immune activation, and fibrosis. The heterogeneity of the disease presents challenges in classification and defining disease outcomes. Patient-reported outcomes have been increasingly used in clinical trials to capture the patient experience. This comprehensive review covers pathogenesis, histopathology, epidemiology, classification systems, and disease outcome measures, with a focus on their relevance to clinical research and trial design.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Article Cell Biology

Lentivirus-mediated subcutaneous JAM-A modification promotes skin wound healing in a mouse model by strengthening the secretory function and proliferation of fibroblasts

Teng Gong et al.

Summary: A better understanding of the molecular regulation of wound healing may provide novel therapeutic targets. The study demonstrates that JAM-A modification accelerates the wound repair process by promoting fibroblast proliferation and increasing the expression of bFGF and EGF growth factors.

CELL BIOLOGY INTERNATIONAL (2022)

Article Cell Biology

The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression

Kamila Czubak-Prowizor et al.

Summary: F11R/JAM-A is a transmembrane glycoprotein of the immunoglobulin superfamily that plays a role in regulating various biological processes in cells. Its involvement in carcinogenesis and tissue-specific roles in cancer progression are still debated topics in research.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)

Review Immunology

The Pathophysiological Roles of Regulatory T Cells in the Early Phase of Systemic Sclerosis

Satomi Kobayashi et al.

Summary: In the early phase of systemic sclerosis (SSc), regulatory T (Treg) cells have been found to play important roles in autoimmunity, vasculopathy, and fibrosis. The increase in Treg cell frequency and dysfunction may contribute to immune disturbances and the progression of the disease. The imbalance between Treg and Th17 cells could also have a significant role in the pathogenesis of early-phase SSc.

FRONTIERS IN IMMUNOLOGY (2022)

Review Cell Biology

The Roles of Junctional Adhesion Molecules (JAMs) in Cell Migration

Junqi Wang et al.

Summary: This review briefly summarizes the role of JAMs in various cell migration and its impact on multiple diseases. JAMs bind to both similar and dissimilar proteins, exerting different effects on different cells. The relevant results provide a reference for further research.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Medicine, General & Internal

Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases

Liala Moschetti et al.

Summary: This review discusses the complex relationship between inflammation, vasculopathy, and fibrosis in patients with systemic lupus erythematosus and systemic sclerosis. It highlights the importance of evaluating endothelial dysfunction and cardiovascular risk in these patients using new techniques.

FRONTIERS IN MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

From the a; b; c; d; e; f; and the g.

Dominik Rath et al.

Summary: Genetic predisposition through F11R-SNVs influences the levels of sJAM-A in CAD patients, resulting in worse prognosis for recurrent myocardial infarction. These genes and proteins affect thrombotic and inflammatory responses through proinflammatory reactions and platelet activation. Intervention in these interactions may regulate thrombotic and inflammatory platelet response in cardiovascular pathologies with elevated circulatory sJAM-A levels.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2022)

Review Immunology

Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells

Konstantinos Melissaropoulos et al.

Summary: Systemic sclerosis is a rare fibrotic rheumatic disease that is associated with psychological distress, skin involvement, and internal organ damage. The understanding of its complex pathogenesis is incomplete and current therapeutic algorithms are not optimal. B cells play a significant role in systemic sclerosis, with imbalances and abnormal receptor signaling being key factors of interest.

FRONTIERS IN IMMUNOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Junctional Adhesion Molecules: Potential Proteins in Atherosclerosis

Junqi Wang et al.

Summary: This review summarizes the roles of JAMs in the development of atherosclerosis and predicts future research directions.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Rheumatology

Insights into molecular and clinical characteristics of very early systemic sclerosis

Silvia Bellando-Randone et al.

Summary: The early diagnosis of systemic sclerosis (SSc) remains a challenge due to overlapping symptoms with other connective tissue diseases. Recent efforts have focused on identifying biomarkers for early SSc. Studies have indicated that some patients classified as sine scleroderma SSc (ssSSc), mixed CTD, and undifferentiated CTD may already be in the very early phase of SSc.

CURRENT OPINION IN RHEUMATOLOGY (2022)

Article Medicine, General & Internal

The Predictive Role of Serum Levels of Soluble Cell Adhesion Molecules (sCAMs) in the Therapy of Advanced Breast Cancer-A Single-Centre Study

Weronika Bulska-Bedkowska et al.

Summary: Soluble cell adhesion molecules (sCAMs) play a significant role in the prognosis and monitoring of the progression of advanced breast cancer (BC). Higher levels of sICAM-1 and lower levels of sEpCAM are associated with faster progression of BC. High levels of sEpCAM throughout the follow-up period are associated with a lower risk of progression. sICAM-1 and sVCAM-1 have independent predictive value for progression-free survival (PFS) and overall survival (OS) in BC.

MEDICINA-LITHUANIA (2022)

Article Biochemistry & Molecular Biology

Soluble JAM-C Ectodomain Serves as the Niche for Adipose-Derived Stromal/Stem Cells

Morio Yamazaki et al.

Summary: Junctional adhesion molecules (JAMs) have been found to exhibit a novel mode of interaction and biological activity in adipose-derived stromal/stem cells, with JAM-C playing a significant role in cell adhesion and proliferation. The cleaved form of JAM-C, sJAM-C, can stimulate adhesion and maintenance of ADSCs in conjunction with JAM-B. These findings suggest a unique functional role of sJAM-C in ADSCs, contributing to not only cell-cell adhesion, but also cell-matrix adhesion.

BIOMEDICINES (2021)

Article Pharmacology & Pharmacy

New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine

Alain Lescoat et al.

Summary: This review discusses new promising therapeutic options under investigation in SSc, highlighting the potential benefits of early combination therapy and the importance of refined patient stratification for improving management strategies in the future.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Review Medicine, General & Internal

Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies

Djulio Cesar Zanin-Silva et al.

Summary: Systemic Sclerosis (SSc) is an autoimmune disease characterized by immune dysregulation, tissue fibrosis and vascular dysfunction. Understanding and treating endothelial damage is crucial, with pharmacological and cellular therapy approaches being used to improve vascular pathology.

FRONTIERS IN MEDICINE (2021)

Review Dermatology

A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis A Narrative Review

Michael Hughes et al.

Summary: Digital ulcers occurring in patients with systemic sclerosis are often painful and disabling, but can be managed with careful clinical assessment and prompt intervention. A structured approach to management, including wound bed management and systemic treatments, is essential to modify the clinical course and improve patient outcomes. Despite available therapeutic options, there are still unmet needs and challenges that require resolution to optimize digital ulcer management.

JAMA DERMATOLOGY (2021)

Article Cell Biology

Role of Junctional Adhesion Molecule-C in the Regulation of Inner Endothelial Blood-Retinal Barrier Function

Xu Hou et al.

Summary: The study found that JAM-C, highly expressed in retinal capillary endothelial cells, translocated from the cytoplasm to the cytomembrane upon treatment with VEGF or PDGF-C. Modulating JAM-C activity in RCECs affected the adhesion and transmigration of macrophages from wet age-related macular degeneration patients, potentially suggesting a therapeutic target for related ocular diseases. Additionally, elevated serum soluble JAM-C levels may serve as a molecular marker for wAMD.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Physiological functions of junctional adhesion molecules (JAMs) in tight junctions

Christian Hartmann et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2020)

Review Cell Biology

The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis

Edith Hintermann et al.

CELLS (2019)

Review Biochemistry & Molecular Biology

Bicellular Tight Junctions and Wound Healing

Junhe Shi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Medicine, General & Internal

Systemic sclerosis

Christopher P. Denton et al.

LANCET (2017)

Review Hematology

Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation

Natalia Reglero-Real et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)

Article Immunology

Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis

Bradley J. Rabquer et al.

JOURNAL OF IMMUNOLOGY (2010)

Article Peripheral Vascular Disease

Elevated Plasma Level of Soluble F11 Receptor/Junctional Adhesion Molecule-A (F11R/JAM-A) in Hypertension

Kwok Leung Ong et al.

AMERICAN JOURNAL OF HYPERTENSION (2009)

Review Oncology

The functional role of cell adhesion molecules in tumor angiogenesis

Chiara Francavilla et al.

SEMINARS IN CANCER BIOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis

Erdal Cavusoglu et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Article Medicine, General & Internal

Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients

Moro O. Salifu et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2007)

Article Biochemistry & Molecular Biology

Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma

Chiaki Fuse et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Immunology

The role of junctional adhesion molecules in vascular inflammation

Christian Weber et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Hematology

Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice

Vesselina G. Cooke et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Junctional Adhesion Molecules (JAMs) are differentially expressed in fibroblasts and co-localize with ZO-1 to adherens-like junctions

Andrew P. Morris et al.

CELL COMMUNICATION AND ADHESION (2006)

Article Biochemistry & Molecular Biology

The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions

S Santoso et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Hematology

Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration

MU Naik et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)